The ability of insulin to inhibit the formation of amyloid by pro-islet amyloid polypeptide processing intermediates is significantly reduced in the presence of sulfated glycosaminoglycans.
about
Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions.Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis.Modulation of amyloid assembly by glycosaminoglycans: from mechanism to biological significance.The Receptor for Advanced Glycation Endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and Exploiting Common Ground for Novel Amyloidosis Therapies.
P2860
The ability of insulin to inhibit the formation of amyloid by pro-islet amyloid polypeptide processing intermediates is significantly reduced in the presence of sulfated glycosaminoglycans.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The ability of insulin to inhi ...... f sulfated glycosaminoglycans.
@en
The ability of insulin to inhi ...... f sulfated glycosaminoglycans.
@nl
type
label
The ability of insulin to inhi ...... f sulfated glycosaminoglycans.
@en
The ability of insulin to inhi ...... f sulfated glycosaminoglycans.
@nl
prefLabel
The ability of insulin to inhi ...... f sulfated glycosaminoglycans.
@en
The ability of insulin to inhi ...... f sulfated glycosaminoglycans.
@nl
P2860
P356
P1433
P1476
The ability of insulin to inhi ...... f sulfated glycosaminoglycans.
@en
P2093
P2860
P304
P356
10.1021/BI4015488
P407
P577
2014-04-18T00:00:00Z